These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24504055

  • 1. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F, Ma W, Ma X, Shao Y, Yang W, Chen X, Li L, Wang J.
    J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
    Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K.
    Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
    [Abstract] [Full Text] [Related]

  • 4. Glucose-6-phosphatase Expression-Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models.
    Kim MJ, Lee CH, Lee Y, Youn H, Kang KW, Kwon J, Alavi A, Carlin S, Cheon GJ, Chung JK.
    Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695
    [Abstract] [Full Text] [Related]

  • 5. Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab.
    Cheyne RW, Trembleau L, McLaughlin A, Smith TA.
    Nucl Med Biol; 2011 Apr; 38(3):339-46. PubMed ID: 21492782
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M.
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [Abstract] [Full Text] [Related]

  • 8. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
    Park SG, Lee JH, Lee WA, Han KM.
    Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N.
    J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
    [Abstract] [Full Text] [Related]

  • 11. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
    Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K.
    Cancer Sci; 2008 Feb; 99(2):260-6. PubMed ID: 18271924
    [Abstract] [Full Text] [Related]

  • 12. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
    Shim HK, Lee WW, Park SY, Kim H, Kim SE.
    Oncol Res; 2009 Feb; 17(7):331-7. PubMed ID: 19408578
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
    Hamann I, Krys D, Glubrecht D, Bouvet V, Marshall A, Vos L, Mackey JR, Wuest M, Wuest F.
    FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
    [Abstract] [Full Text] [Related]

  • 16. Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
    Tong SY, Lee JM, Ki KD, Choi YJ, Seol HJ, Lee SK, Huh CY, Kim GY, Lim SJ.
    Int J Gynecol Cancer; 2012 May; 22(4):654-8. PubMed ID: 22398711
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.
    Engles JM, Quarless SA, Mambo E, Ishimori T, Cho SY, Wahl RL.
    J Nucl Med; 2006 Apr; 47(4):603-8. PubMed ID: 16595493
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.